Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [731]

Toripalimab plus chemotherapy improves 3-year survival in resectable gastric...

Dr Shu-Qiang Yuan - Sun Yat-sen University Cancer Center, Guangzhou, China

Toripalimab plus chemotherapy improves 3-year survival in resectable gastric/GEJ cancer ( Dr Shu-Qiang Yuan - Sun Yat-sen University Cancer Center, Guangzhou, China )

Physical activity reduces fatigue and improves quality of life in colorectal...

Dr Louisa Liu - Cedars-Sinai Medical Center, Los Angeles, USA

Physical activity reduces fatigue and improves quality of life in colorectal cancer survivors ( Dr Louisa Liu - Cedars-Sinai Medical Center, Los Angeles, USA )

Zanidatamab improves PFS and OS in first-line HER2-positive metastatic gastric...

Dr Elena Elimova - The Princess Margaret Hospital, Toronto, Canada

Zanidatamab improves PFS and OS in first-line HER2-positive metastatic gastric cancer ( Dr Elena Elimova - The Princess Margaret Hospital, Toronto, Canada )

Understanding anal cancer risk among people with HIV in sub-Saharan Africa

Dr Eliane Rohner - University of Bern, Bern, Switzerland

Understanding anal cancer risk among people with HIV in sub-Saharan Africa ( Dr Eliane Rohner - University of Bern, Bern, Switzerland )

Post-treatment exercise programme improves survival for stage II/III colon...

Dr Christopher Booth - Queen's University, Kingston, Canada

Post-treatment exercise programme improves survival for stage II/III colon cancer ( Dr Christopher Booth - Queen's University, Kingston, Canada )

Choosing Wisely: Managing resectable colorectal liver metastases

Dr Christopher Jackson - University of Otago, Otago, New Zeland

Choosing Wisely: Managing resectable colorectal liver metastases ( Dr Christopher Jackson - University of Otago, Otago, New Zeland )

Optimal management of gastric cancers

Dr Prasanth Penumadu - Institution of Cancer Care & Advanced Research...

Optimal management of gastric cancers ( Dr Prasanth Penumadu - Institution of Cancer Care & Advanced Research , Tirupati, India. )

Choosing Wisely: ctDNA/ Precision Oncology in colorectal cancers

Dr Aparna Parikh - Massachusetts General Hospital, Boston, EE.UU

Choosing Wisely: ctDNA/ Precision Oncology in colorectal cancers ( Dr Aparna Parikh - Massachusetts General Hospital, Boston, EE.UU )

Temab-A plus bevacizumab shows promising response rates in advanced colorectal...

Dr Michael Cecchini - Yale School of Medicine, New Haven, USA

Temab-A plus bevacizumab shows promising response rates in advanced colorectal cancer ( Dr Michael Cecchini - Yale School of Medicine, New Haven, USA )

ESMO 2025: Highlights and analysis

Assoc Prof Bishal Gyawali - Queen's University, Kingston, Canada

ESMO 2025: Highlights and analysis ( Assoc Prof Bishal Gyawali - Queen's University, Kingston, Canada )

ctDNA-guided adjuvant chemo de-escalation reduces toxicity with comparable...

Dr Jeanne Tie - Peter MacCallum Cancer Centre, Melbourne, Australia

ctDNA-guided adjuvant chemo de-escalation reduces toxicity with comparable outcomes in stage III colon cancer ( Dr Jeanne Tie - Peter MacCallum Cancer Centre, Melbourne, Australia )

Trastuzumab deruxtecan demonstrates advance in treatment for HER2-positive...

Dr Yelena Janjigian - Memorial Sloan Kettering Cancer Center, New York, USA

Trastuzumab deruxtecan demonstrates advance in treatment for HER2-positive gastric cancer ( Dr Yelena Janjigian - Memorial Sloan Kettering Cancer Center, New York, USA )

More from ecancer